What is cancer immunotherapy?
A subset of cancer patients undergoing immunotherapy have displayed robust and long-lasting therapeutic responses. Currently, the spotlight is on the use of blocking antibodies against the T-cell checkpoint molecules, cytotoxic T-lymphocyte-associated antigen 4 (CTLA-4) and programed cell death-1 (...
Cancer Immunology, Immunotherapy is providing a timely and open access publication of original discovery and developments in basic and translational research ...
And then we realized really, over time, from the work of Jim Allison and others—and actually Carl June and Paul Martin when Carl was at the Fred Hutchinson Cancer Center—that there were multiple positive and negative signals that were present on the surface of T cells.So, what we ...
Immunotherapy and Cancer Cancer is usually treated by either radiotherapy, chemotherapy, surgery, or various combinations of all three. These forms of treatment are very successful and are still used today. However, research is being conducted into stimulating the immune system to attack cancers from...
2024年4月23日,上海寻百会生物科技有限公司肖腾飞、GV20 Therapeutics LLC 刘小乐(X. Shirley Liu)及Xihao Hu共同通讯在Cell在线发表题为“IGSF8 is an innate immune checkpoint and cancer immunotherapy target”的研究论文,该研究...
Q2:What are some of the significant breakthroughs in liver cancer research that have been made in recent years? How have these breakthroughs impacted clinical practice? Tim Meyer:I guess the major advances in the past few years have been in systemic therapy. So, for many years, we had tyrosi...
of imaging tests, blood tests, and biopsy results to diagnose lung cancer. Your choice of treatment depends on the type and stage of cancer you have, as well as your health. Surgery, radiation, chemotherapy, immunotherapy, and targeted therapy are just some of the treatments for lung cancer....
What is the pathophysiology of lung cancer? What is a lung cancer screening? What are the types of treatment for lung cancer? What is proton therapy for lung cancer? What are the underlying principles of immunotherapy for cancer treatment?
Perhaps it should be a lesson to all of us that regulation and innovation can be calibrated more effectively during “normal” times as industry races to develop new therapies for other epidemics—cancer, diabetes, heart disease, and more. The next step of the process—distribution of the ...